What is the current Price Target for the Eliem Therapeutics Inc stock?

The average Eliem Therapeutics Inc target price is $22.44. This is 92.45% higher than the current stock price. The highest price target is 215.18%, the lowest is 55.92%. 16 Analysts have issued a price target Eliem Therapeutics Inc 2027 .

How high will the Eliem Therapeutics Inc stock rise?

No reliable answer can be given as to how high the Eliem Therapeutics Inc stock will rise. The performance of stocks, including the Eliem Therapeutics Inc stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Eliem Therapeutics Inc stock today?

The performance of Eliem Therapeutics Inc stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Eliem Therapeutics Inc stock fall?

The decline in Eliem Therapeutics Inc stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Eliem Therapeutics Inc Forecast, price target & analysts

$11.66

1.93%

Nasdaq, Sep 25, 04:00 pm EDT. Closed.

ISIN

US28658R1068

Symbol

CLYM

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Analysts Charts Ownership News Strategies

Eliem Therapeutics Inc Target price 2026 - Analyst rating & recommendation

Eliem Therapeutics Inc Classifications & Recommendation

Buy

95%

Hold

Eliem Therapeutics Inc Price Target

Target Price	$22.44
Price	$11.66
Potential	92.45% register free of charge
Number of Estimates	16

	16 Analysts have issued a price target Eliem Therapeutics Inc 2027 . The average Eliem Therapeutics Inc target price is $22.44. This is 92.45% register free of charge higher than the current stock price. The highest price target is $36.75 215.18% register free of charge , the lowest is $18.18 55.92% register free of charge .
	A rating was issued by 21 analysts: 20 Analysts recommend Eliem Therapeutics Inc to buy, 1 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Eliem Therapeutics Inc stock has an average upside potential 2027 of 92.45% register free of charge . Most analysts recommend the Eliem Therapeutics Inc stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033

Create a premium account to unlock analyst estimates. Learn more

Annually

	Dec '25	2026 Estimates
Earnings Per Share $	-0.88	-0.81
	42.48%	7.95%
P/E		negative

17 Analysts have issued a Eliem Therapeutics Inc forecast for earnings per share. The average Eliem Therapeutics Inc EPS is

unlock

. This is

unlock

than earnings per share in the financial year 2025. The highest EPS forecast is

unlock

, the lowest is

unlock

This results in the following potential growth metrics and future valuations:

2025	$-0.88	42.48%
2026	$-0.81 7.95% unlock
2027	$-1.00 23.46% unlock
2028	$-1.27 27.00% unlock
2029	$-2.27 78.74% unlock
2030	$-2.52 11.01% unlock
2031	$-2.07 17.86% unlock
2032	$-0.48 76.81% unlock
2033	$1.41 393.75% unlock

Current	-15.85	373.54%
2026	-14.70 7.27% unlock
2027	-11.94 18.78% unlock
2028	-9.37 21.52% unlock
2029	-5.23 44.18% unlock
2030	-4.72 9.75% unlock
2031	-5.74 21.61% unlock
2032	-25.01 335.71% unlock
2033	8.45 133.79% unlock

Eliem Therapeutics Inc...

Current Eliem Therapeutics Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
Oppenheimer	Locked ➜ Locked	Locked	Sep 08 2026
HC Wainwright & Co.	Locked ➜ Locked	Locked	Sep 08 2026
B. Riley Securities	Locked ➜ Locked	Locked	Sep 04 2026
BTIG	Locked ➜ Locked	Locked	Sep 03 2026
Baird	Locked ➜ Locked	Locked	Sep 03 2026
HC Wainwright & Co.	Locked ➜ Locked	Locked	Aug 24 2026
Wedbush	Locked ➜ Locked	Locked	Aug 19 2026

Analyst Rating	Date
Locked Oppenheimer: Locked ➜ Locked	Sep 08 2026
Locked HC Wainwright & Co.: Locked ➜ Locked	Sep 08 2026
Locked B. Riley Securities: Locked ➜ Locked	Sep 04 2026
Locked BTIG: Locked ➜ Locked	Sep 03 2026
Locked Baird: Locked ➜ Locked	Sep 03 2026
Locked HC Wainwright & Co.: Locked ➜ Locked	Aug 24 2026
Locked Wedbush: Locked ➜ Locked	Aug 19 2026

Discover more stocks with a high price target

NIO ADR 104.57%

Alibaba Group Holding Ltd 70.15%

Rheinmetall 66.12%

Infineon 62.78%

Tencent Holdings Ltd. 56.53%

Adyen 53.79%

TUI 52.57%

Uber Technologies 47.97%

BYD 47.08%

Siemens Energy 46.63%

Adidas 42.38%

Deutsche Telekom 37.89%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now